We have identified a tumor suppressor role of MG53 and its negative regulation of RAC1 signaling, and then we further try to demonstrate whether the anti-tumor effect of MG53 is mediated through RAC1-MAPK signaling. The gene discussed is RAC1; the disease is neoplasm.